1
|
Al Haqimy Mohammad Yunus MA, Akkawi ME, Fata Nahas AR. Investigating the association between medication regimen complexity, medication adherence and treatment satisfaction among Malaysian older adult patients: a cross-sectional study. BMC Geriatr 2024; 24:447. [PMID: 38778251 PMCID: PMC11110348 DOI: 10.1186/s12877-024-05016-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Accepted: 04/26/2024] [Indexed: 05/25/2024] Open
Abstract
BACKGROUND The prevalence of medication nonadherence among Malaysian older adults is approximately 60%. However, there is a lack of studies assessing the factors associated with medication nonadherence among this population. This research aims to explore the association between medication regimen complexity (MRC), treatment satisfaction and medication adherence among Malaysian older adults. METHOD A cross-sectional study was conducted in outpatient clinics of a teaching hospital in Pahang, Malaysia, between April 2023 and September 2023. MRC Index (MRCI), Treatment Satisfaction for Medication version II (TSQM v.II), and the Malaysian Medication Adherence Assessment Tool (MyMAAT) were used. Multivariate linear and logistic regression models were performed to test the factors affecting treatment satisfaction and medication adherence. Mediator analysis was implemented to assess the mediating role of treatment satisfaction. RESULT The study involved 429 Malaysian older adult patients, with a prevalence of nonadherence of 51.0% (n = 219) and an MRCI mean score of 17.37 (SD = 7.07). The mean overall treatment satisfaction score was 73.91 (SD = 15.23). Multivariate logistic regression analysis expressed four significant predictors associated with nonadherence: MRC (AOR = 1.179, p = 0.002), overall treatment satisfaction (AOR = 0.847, p < 0.001), partially self-managed medication (AOR = 2.675, p = 0.011) and fully managed medication by family members/caregivers (AOR = 8.436, p = 0.004). Multivariate linear regression shows three predictors of treatment satisfaction: MRC (β = -1.395, p < 0.001), Charlson Comorbidity Index (CCI) (β = -0.746, p = 0.009) and self-managed medication (β = 5.554, p = 0.006). Mediator analysis indicated that treatment satisfaction partially mediated the association between MRC and nonadherence. CONCLUSION Nonadherence was quite prevalent among Malaysian older outpatients and was associated with regimen complexity, treatment satisfaction and patient dependence on others to manage their medications. Future studies should focus on interventions to control the factors that negatively affect patients' medication adherence.
Collapse
Affiliation(s)
| | - Muhammad Eid Akkawi
- Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia.
- Quality Use of Medicines Research Group, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia.
| | - Abdul Rahman Fata Nahas
- Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia
- Quality Use of Medicines Research Group, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia
| |
Collapse
|
2
|
Kim HJ, Kim HY. [Factors influencing the health-related quality of life of postmenopausal women with diabetes and osteoporosis: a secondary analysis of the Seventh Korea National Health and Nutrition Examination Survey (2016-2018)]. KOREAN JOURNAL OF WOMEN HEALTH NURSING 2022; 28:112-122. [PMID: 36312859 PMCID: PMC9334181 DOI: 10.4069/kjwhn.2022.05.25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 05/24/2022] [Accepted: 05/25/2022] [Indexed: 11/22/2022] Open
Abstract
Purpose The prevalence of osteoporosis in postmenopausal women is increasing, and diabetes patients have decreased bone density. Their health-related quality of life (HRQoL) is diminished by the resultant physical dysfunction and depression. The purpose of this study was to identify factors influencing HRQoL in postmenopausal women with diabetes and osteoporosis. Methods This was a secondary data analysis of the Seventh Korea Health and Nutrition Examination Survey (2016-2018), which utilized a complex, multistage probability sample design. The participants in the study were 237 women with diabetes and osteoporosis. To evaluate the factors that influenced HRQoL, a complex-samples general linear model was constructed, and the Bonferroni correction was performed. Results In this sample of women aged 45 to 80 years (mean±standard deviation, 71.12±7.21 years), the average HRQoL score was 0.83±0.18 out of 1.0. Factors influencing HRQoL were age (70s: t=-3.74, p<.001; 80s: t=-3.42, p=.001), walking for exercise more than 5 days a week (t=-2.83, p=.005), cerebrovascular disease (t=-8.33, p<.001), osteoarthritis (t=-2.04, p=.014), hypertension (t=2.03, p=.044), higher perceived stress (t=-2.17, p=.032), poor glycemic control (t=3.40, p=.001), waist circumference (t=-2.76, p=.007), sitting time per day (t=-2.10, p=.038), and a longer postmenopausal period (t=3.09, p=.002). Conclusion In order to improve the HRQoL of postmenopausal women with osteoporosis and diabetes, it is necessary to implement intervention strategies that enable the effective management of chronic diseases, while preventing the complications of diabetes and minimizing stress through physical activity.
Collapse
Affiliation(s)
| | - Hye Young Kim
- Corresponding author: Hye Young Kim College of Nursing, Jeonbuk National University, 567 Baekje-daero, Deokjin-gu, Jeonju 54896, Korea Tel: +82-63-270-4618 E-mail:
| |
Collapse
|
3
|
Lee S, Kim Y, Lee S, Lee SH, Kim Y, Jeon J, Jo J, Yoo H, Lee J, Kim T. Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross‐sectional observational study. Int J Rheum Dis 2022; 25:523-531. [PMID: 35187866 PMCID: PMC9303183 DOI: 10.1111/1756-185x.14304] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2021] [Revised: 01/21/2022] [Accepted: 01/22/2022] [Indexed: 12/17/2022]
Affiliation(s)
- Sang‐Hoon Lee
- Department of Rheumatology, Hospital at Gangdong Kyung Hee University Seoul Korea
| | - Yong‐Gil Kim
- Department of Rheumatology Asan Medical Center University of Ulsan College of Medicine Seoul Korea
| | - Seung‐Geun Lee
- Department of Rheumatology Pusan National University Hospital Pusan Korea
| | - Soo Hyun Lee
- Division of Medical Pfizer Biopharmaceuticals Group Pfizer Pharmaceuticals Korea Limited Seoul Korea
| | - Young‐Joo Kim
- Division of Medical Pfizer Biopharmaceuticals Group Pfizer Pharmaceuticals Korea Limited Seoul Korea
| | - Ja‐Young Jeon
- Division of Medical Pfizer Biopharmaceuticals Group Pfizer Pharmaceuticals Korea Limited Seoul Korea
| | - Joo‐Young Jo
- Division of Medical Pfizer Biopharmaceuticals Group Pfizer Pharmaceuticals Korea Limited Seoul Korea
| | - Hyun‐Jeong Yoo
- Division of Medical Pfizer Biopharmaceuticals Group Pfizer Pharmaceuticals Korea Limited Seoul Korea
| | - Juneyoung Lee
- Department of Biostatistics College of Medicine Korea University Seoul Korea
| | - Tae‐Hwan Kim
- Department of Rheumatology Hanyang University Hospital for Rheumatic Diseases Seoul Korea
| |
Collapse
|
4
|
Leong R, Owusu L, Tang J, John N, Voyer KE, Gargala E, Daigler B, Ma Q, Morse GD, Cha R. Patient-reported outcomes for HIV: the future of long-acting injectables and antiretroviral therapy evaluations. Future Virol 2021. [DOI: 10.2217/fvl-2020-0322] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Patient-reported outcomes (PROs) are an increasingly important aspect of patient care, as they offer a perspective from the patient themselves in the treatment and management of a particular disease state. They have a potential role in helping clinicians select an appropriate drug regimen in human immunodeficiency virus-1 (HIV-1)-infected individuals, as well as those with HIV/hepatitis C (HCV) co-infection. They can also provide insight for individuals receiving long-acting (LA) injectable antiretroviral therapy (ART). Studies found from PROs that participants on an LA injectable ART regimen reported greater preference and treatment satisfaction compared with those on an oral ART regimen. Some additional studies have also used PROs to evaluate the switch to single-tablet regimens and compare different ART in treating HIV-1. Current PROs and how they can be improved for LA injectables were also discussed.
Collapse
Affiliation(s)
- Richard Leong
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
| | - Leon Owusu
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
| | - Jerrica Tang
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
| | - Neeraj John
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
| | - Kira E Voyer
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
| | - Emma Gargala
- Department of Pharmacy, Catholic Health System, Buffalo, NY 14214, USA
| | - Benjamin Daigler
- Department of Pharmacy, Catholic Health System, Buffalo, NY 14214, USA
| | - Qing Ma
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
- Department of Pharmacy, Center for Integrated Global Biomedical Sciences, Buffalo, NY 14214, USA
| | - Gene D Morse
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
- Department of Pharmacy, Center for Integrated Global Biomedical Sciences, Buffalo, NY 14214, USA
| | - Raymond Cha
- Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA
- Department of Pharmacy, Center for Integrated Global Biomedical Sciences, Buffalo, NY 14214, USA
- Department of Pharmacy, Catholic Health System, Buffalo, NY 14214, USA
| |
Collapse
|
5
|
Zhou Y, Xue X, Guo Y, Liu H, Hou Z, Chen Z, Wang N, Li F, Wang Y. A quinoxaline-based compound ameliorates bone loss in ovariectomized mice. Exp Biol Med (Maywood) 2021; 246:2502-2510. [PMID: 34308655 DOI: 10.1177/15353702211032133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
DMB (6,7-dichloro-2-methylsulfonyl-3-Ntert-butylaminoquinoxaline) is a quinoxaline-based compound that has been investigated as a glucagon-like peptide-1 receptor (GLP-1R) agonist. To clarify anti-osteoporosis effect of DMB, an osteoporotic mice model was established by ovariectomy (OVX) operation. The OVX mice were given intraperitoneally DMB, exendin-4 (EX-4), or 17β-estradiol (E2) for two months. Then bone mass and structure, and bone morphometric parameters were examined by micro-CT. Weight gain and food consumption, bone turnover markers, and biomechanical strength of the femur were tested, and bone histomorphometry was analyzed. The food intake and weight gain was obviously reduced by E2 or EX-4, but not DMB. However, DMB or EX-4 treatment obviously inhibited skeletal deterioration and enhanced bone strength. The improvement involved in the increased osteoblast number and level of bone formation markers, and reduced osteoclasts number and level of bone resorption markers. In addition, DMB was found to stimulate osteoblastogenesis-related marker gene expression. These results demonstrated that DMB ameliorated bone loss mainly via induction of bone formation, which suggests that the small molecule compound might be applied to the management of postmenopausal osteoporosis.
Collapse
Affiliation(s)
- Ying Zhou
- Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China.,Science and Technology Innovation Platform of Shaanxi Provincial Research Center for Project of Prevention and Treatment of Respiratory Diseases, Xi'an Medical University, Xi'an 710021, PR China
| | - Xiaoyan Xue
- Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China
| | - Yanyan Guo
- Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038, PR China
| | - Huan Liu
- Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China
| | - Zheng Hou
- Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China
| | - Zhou Chen
- Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China
| | - Ning Wang
- Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China
| | - Fen Li
- Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China
| | - Yang Wang
- Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China
| |
Collapse
|
6
|
Park YS, Hwang TJ, Cho GJ, Kim SK, Park SK, Kim JY, Baek HJ, Kim Y, Lee H, Shin J, Nam C, Sun J, Yoo KY. Patients' and parents' satisfaction with, and preference for, haemophilia A treatments: a cross-sectional, multicentre, observational study. Haemophilia 2021; 27:563-573. [PMID: 34128300 PMCID: PMC8362144 DOI: 10.1111/hae.14304] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2020] [Revised: 03/08/2021] [Accepted: 03/15/2021] [Indexed: 01/18/2023]
Abstract
INTRODUCTION Reports on patients' satisfaction and preferred characteristics for treatments would be worthwhile when choosing an optimal treatment reflecting patients' perspectives. AIM To identify the characteristics and treatment patterns of patients with haemophilia A, or their caregivers, in Korea and explore patient preferences and satisfaction with their treatment. METHODS This cross-sectional, multicentre, observational study was conducted from April 2018 to September 2019 at six nationwide hospitals and three Korea Hemophilia Foundation clinics. Patients aged ≥16 years, or legal caregivers of paediatric patients, who had used factor VIII (FVIII) concentrates for ≥1 month were enrolled. Satisfaction with treatment was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM); preference was evaluated using discrete choice experiment (DCE), with 10 series of two hypothetical treatment options created from D-efficient block design, which varied across five attributes. RESULTS Overall, 505 patients (mean age 31 years) were enrolled in the study. Patients had received FVIII concentrate for an average of 102.9 months (prophylaxis: 53.5%; on-demand: 22.2%). Mean TSQM scores were 64.6 (effectiveness domain), 97.9 (side effects), 57.1 (convenience) and 66.8 (global satisfaction). The number of vials per injection, and the frequency of drug administration, was significantly associated with treatment satisfaction. According to DCE, simpler treatment options were preferred by patients/caregivers. CONCLUSION The lowest satisfaction levels were shown in the treatment convenience domain. Patients/parents preferred simpler and easier treatment characteristics. In an attempt to enhance the overall satisfaction of patients and caregivers with treatment, consideration of more convenient characteristics is required in future decisions regarding treatment selection.
Collapse
Affiliation(s)
- Young Shil Park
- Department of PediatricsKyung Hee University Hospital at GangdongSeoulSouth Korea
| | - Tai Ju Hwang
- Korea Hemophilia Foundation Gwangju ClinicGwang‐JuSouth Korea
| | - Goon Jae Cho
- Korea Hemophilia Foundation Busan ClinicBusanSouth Korea
| | - Soon Ki Kim
- Department of PediatricsInha University HospitalIncheonSouth Korea
| | - Sang Kyu Park
- Department of PediatricsUlsan University HospitalUlsanSouth Korea
| | - Ji Yoon Kim
- Department of PediatricsKyungpook National University HospitalDaeguSouth Korea
- Department of Pediatric Hematology and OncologyKyungpook National University Chilgok HospitalDaeguSouth Korea
| | - Hee Jo Baek
- Department of PediatricsChonnam National University Hwasun HospitalChonnam National University Medical SchoolGwangjuSouth Korea
| | - Young‐Joo Kim
- Medical DepartmentPfizer Pharmaceuticals Korea LtdSeoulSouth Korea
| | - Ho‐Jin Lee
- Medical DepartmentPfizer Pharmaceuticals Korea LtdSeoulSouth Korea
| | - Ji‐Soo Shin
- Medical DepartmentPfizer Pharmaceuticals Korea LtdSeoulSouth Korea
| | - Chung‐Mo Nam
- Department of Biostatistics and ComputingYonsei UniversitySeoulSouth Korea
| | - Jiyu Sun
- Department of Biostatistics and ComputingYonsei UniversitySeoulSouth Korea
| | - Ki Young Yoo
- Korea Hemophilia Foundation Clinic (KHF ClinicSeoulSouth Korea
| |
Collapse
|
7
|
Ban J, Peng L, Li P, Liu Y, Zhou T, Xu G, Zhang X. Performance of Double-Arm Digital Subtraction Angiography (DSA)-Guided and C-Arm-Guided Percutaneous Kyphoplasty (PKP) to Treat Senile Osteoporotic Vertebral Compression Fractures. Med Sci Monit 2020; 26:e923619. [PMID: 32799216 PMCID: PMC7448688 DOI: 10.12659/msm.923619] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Background Osteoporotic vertebral compression fracture (OVCF) is a common fracture in the elderly. Conservative treatment requires prolonged bedding, which may lead to serious complications. To explore optimized use of percutaneous kyphoplasty (PKP) in the treatment of senile osteoporotic thoracolumbar vertebral compression fractures, in this study, we used C-arm-guided and double-arm digital subtraction angiography (DSA)-guided PKP to treat OVCF in elderly patients and analyzed the effective recovery. Material/Methods In all, 60 patients who presented with osteoporotic vertebral compression fractures at our hospital between July 2017 and February 2019 were analyzed. They were randomly divided into C-arm-guided group and the double-arm DSA-guided groups. Both groups were treated with percutaneous kyphoplasty. Results A pain VAS score analysis revealed that there was no significant difference between the two groups before surgery (P>0.05). After surgery, the VAS scores showed a significant difference between the C-arm-guided group and the double-arm DSA-guided PKP treatment group (P<0.01). Moreover, with respect to the bone cement dosage, vertebral correction height, operation time, cumulative radiation dose, percolation rate, and volume of bone cement, the double-arm DSA-guided PKP treatment showed significantly better results than the C-arm-guided PKP treatment (P<0.01). Conclusions Our data revealed that double-arm DSA-guided PKP was more accurate in treatment of senile osteoporotic thoracolumbar vertebral compression fractures, producing excellent performance with more accurate intraoperative evaluation, shorter operative time, lower incidence of bone cement leakage, less intraoperative radiation dose, and higher safety, and thus, could be extensively applied to clinical surgery.
Collapse
Affiliation(s)
- Jihe Ban
- Department of Orthopedics, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China (mainland)
| | - Lilu Peng
- Department of Orthopedics, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China (mainland)
| | - Pengpeng Li
- Department of Orthopedics, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China (mainland)
| | - Yunhai Liu
- Department of Orthopedics, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China (mainland)
| | - Tao Zhou
- Department of Invasive Technology, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China (mainland)
| | - Guangtao Xu
- Forensic and Pathology Laboratory, Judicial Expertise Center, Jiaxing University Medical College, Jiaxing, Zhejiang, China (mainland)
| | - Xingen Zhang
- Department of Orthopedics, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China (mainland)
| |
Collapse
|